infarction rates were similar among the groups. However, the matched groups revealed TCAR was associated with a decreased rate of mortality at 30 days (0.0% vs 2.3%; P ¼ .026).
confer risk for neurocognitive impairment. Patients undergoing stenting are known to be at higher risk for microemoblization. In this prospective cohort study, we compared the microembolization rates for patients undergoing CAS and CEA and patient and perioperative characteristics that may be associated with microembolization.
Methods: Patients undergoing CAS and CEA were prospectively recruited under local institutional review board approval from an academic medical center. All patients also received 3T brain magnetic resonance imaging with a diffusion-weighted imaging sequence preoperatively and within 48 hours postoperatively to identify procedure-related new embolic lesions. Preoperative, postoperative, procedural factors, and plaque characteristics were collected. Factors were tested for statistical significance with logistic regression.
Results: There were 202 patients enrolled in the study; 107 underwent CAS and 95 underwent CEA. Patients undergoing CAS were more likely to have microemboli than patients undergoing CEA (78% vs 27%; P < .05). For patients undergoing CAS, patency of the external carotid artery (odds ratio, 11.4; 95% confidence interval, 1.11-117.6; P ¼ .04), lesion calcification (odds ratio, 5.68; 95% confidence interval, 1.12-28.79; P ¼ .04), and lesion length (odds ratio, 0.29; 95% confidence interval, 0.08-1.01; P ¼ .05) were all found to be independent risk factors for postoperative embolization. These factors did not confer increased risk to patients undergoing CEA. 
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June 2018 Conclusions: Patients undergoing CAS are at higher risk for postoperative embolization. The risk for postoperative embolization is related to the length of the lesion and calcification. Identifying the preoperative risk factors may help to guide patient selection and, thereby, reduce embolization-related neurocognitive impairment. Understanding these risky lesions may also help to guide the selection of technique when selecting CAS or CEA for a patient and decrease morbidity. Patients undergoing stenting for atherosclerotic disease, therefore, may be at greater risk for embolization and neurocognitive impairment than those undergoing CAS for radiation-induced stenosis or other indications.
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PC070. Preoperative Silent Brain Infarcts Have a Significant Impact on Both Carotid Endarterectomy and Stenting
Laura Cacioppa, GianLuca Faggioli, Rodolfo Pini, Andrea Vacirca, Martina Goretti, Enrico Gallitto, Gargiulo Mauro, Andrea Stella. University of Bologna, Bologna, Italy
Objectives: The presence of silent cerebral infarcts (SCIs) in patients submitted to carotid revascularization has been extensively studied in patients undergoing carotid endarterectomy (CEA); however, few data exist about their influence in those undergoing carotid artery stenting (CAS). The aim of our study was to assess the different impact of SCIs on CAS and CEA.
Methods: All consecutive carotid revascularizations performed either by CEA or CAS in our center over an 11-year period (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) in asymptomatic patients, were recorded and retrospectively reviewed. SCIs were defined as cerebral embolic infarcts in the anterior or middle cerebral artery territory, ipsilateral to the target carotid stenosis, identified by preoperative brain computed tomography (CT) scanning, according to the Stevens Classification. Perioperative (30-day) stroke, death and transient ischemic attack rates were evaluated in patients with and without preoperative SCIs.
Results: Over a total of 743 CEA and 418 CAS procedures in asymptomatic patients, 743 (100%) and 347 (83%) performed a preoperative CT scan, respectively. In patients submitted to CEA stroke and death outcomes at 30 days were 0.5% and 0.7%, respectively, and 97 (13.1%) demonstrated SCI as defined by the Stevens Classification. CEA patients with SCI had a significantly higher 30-day stroke outcome (3.1% vs 0.2%; odds ratio, 16.39; 95% confidence interval, 1.33-201.4; P ¼ .001) compared with those without SCI. In a CAS population with a preoperative CT scan, we observed 6 strokes (1.7%), no deaths, 17 transient ischemic attacks (4.9%), and 46 CT scans positive for SCI (13.3%). The CAS population with SCI had a significantly higher 30-day stroke outcome (6.5% vs 1%; odds ratio, 6.9; 95% confidence interval, 1.35-35.4; P ¼ .03) compared with patients submitted to CAS with a SCI negative CT scan. Conversely, the 30-day transient ischemic attack rates were similar in patients positive and negative for SCI (6.5% vs 4.7%; odds ratio, 1.4; 95% confidence interval, 0.39-5.18; P ¼ .39). In the CAS population, SCI was confirmed as an independent risk factor for 30-day stroke by Cox regression (hazard ratio, 8.7; 95% confidence interval, 1.54-49.6; P ¼ .01).
Conclusions: SCI is a common preoperative finding in asymptomatic patients submitted to carotid revascularization. In both CEA and CAS procedures the presence of SCI is associated with a higher postoperative stroke outcome. Moreover, preoperative SCI in the CAS population can be considered an independent risk factor for 30-day stroke.
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PC072.
The Impact of Stent Geometry on Outcomes of Carotid Artery Stenting Objectives: Carotid artery stenting (CAS) is now a well-established minimally invasive procedure for treatment of carotid stenosis. Whereas the atherosclerotic plaque is completely removed in carotid endarterectomy, CAS is designed to cover and stabilize the plaque with the stent struts. 
